Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
25 hedge funds and large institutions have $11.4M invested in Psychemedics Corporation in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 6 closing their positions.
11% less funds holding
Funds holding: 28 → 25 (-3)
18% less capital invested
Capital invested by funds: $13.9M → $11.4M (-$2.54M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell Capital
Alta,
Wyoming
|
+$568K |
| 2 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$9.29K |
| 3 |
BlackRock
New York
|
+$7.81K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.71K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$648 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$505K |
| 2 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$137K |
| 3 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$115K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$113K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$108K |
PMD Hedge Fund Activity: Q4 2021 in Review
25 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2021, worth a combined $11.4M — down 18% from $13.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PMD and 3 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 4 added.
The largest buyer was Cannell Capital, opening a new position worth an estimated $568K. The largest seller was Tieton Capital Management, exiting entirely with an estimated $505K sold.
- 25 institutional investors held Psychemedics Corporation (PMD) as of Q4 2021, down from 28 in Q3 2021.
- Funds reported $11.4M of Psychemedics Corporation stock for Q4 2021, down 18% quarter-over-quarter.
- 3 funds opened new Psychemedics Corporation positions in Q4 2021 and 6 closed out, a net change of -3 holders.
- The largest Psychemedics Corporation buyer in Q4 2021 was Cannell Capital, an estimated $568K added.
- The largest Psychemedics Corporation seller in Q4 2021 was Tieton Capital Management, an estimated $505K sold.
Based on aggregated 13F filings for Q4 2021.